Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Brivaracetam in the Real World: Tackling Unmet Needs in FOS
4
Mins
December 2025
Many people living with focal onset seizures (FOS) fail to achieve seizure freedom, even after taking two or more anti-seizure..
Read more
13
Mins
29 Aug 2025
Evidence on VNS in the Modern DRE Treatment Landscape
Epilepsy affects around 50 million people worldwide. Approximately 30% of them experience drug-resistant epilepsy (DRE), which…
4
Mins
5 Aug 2025
Spotlight on CIDP
Exploration of key data on chronic inflammatory demyelinating polyneuropathy (CIDP) presented at EHA 2025. Post-hoc analysis of the ADHERE…
2
Mins
5 Aug 2025
How Clinicians Can Encourage People with Multiple Sclerosis
Multiple sclerosis (MS) is a complex, lifelong neurological condition that presents with unpredictable symptoms, progressive disability…
15
Mins
5 Aug 2025
Precision Medicine in Neurology: Advancing Care for Female Patients
Historically, sex-related differences have been underexplored in neurology. It is important to highlight the distinction between sex and…
13
Mins
5 Aug 2025
The Intersection of Menopause and Epilepsy
Epilepsy is a serious and common neurological condition, characterised by recurring, unprovoked seizures, affecting approximately 25…
5
Mins
5 Aug 2025
The Versatility of Neurosonology: Vertebrobasilar Pathology
Neurosonology is a versatile, non-invasive diagnostic modality for evaluating cerebral circulatory disorders.1 It provides real-time…
5
Mins
29 Jul 2025
CIDP Through a Patient’s Lens
In this patient-focused interview, EMJ spoke to Jean-Philippe Plançon, a patient with chronic inflammatory demyelinating….
7
Mins
24 Jul 2025
Patient Advocacy in Huntington's: Interview with Astri Arnesen
It all began when my mother was diagnosed with Huntington’s disease. At the time, Huntington’s was a rare disease, and it still is by…
7
Mins
24 Jul 2025
Psychedelics in Psychiatry: Interview with Christina Dalla
EMJ spoke with Christina Dalla, a pioneering researcher in neuropsychopharmacology and expert in sex differences in neuropsychiatric…
3
Mins
17 Jul 2025
Regenerating Neural Function: Interview with Lukas Rasulic
EMJ spoke with Lukas Rasulic to explore the latest advances in peripheral nerve repair, the integration of functional neurosurgery, and…
6
Mins
27 Jun 2025
Critical Management of Neurocysticercosis with Hydrocephalus
Neurocysticercosis, a parasitic brain infection caused by the larvae of Taenia solium that leads to cysts in the central nervous system…
4
Mins
26 Jun 2025
Mitigating the Treatment Gap in Drug-Resistant Epilepsy
For this article, EMJ conducted an interview with Ahmed Abdelmoity, Professor and Director, Division of Neurology, Children’s Mercy…
5
Mins
5 Jun 2025
CAR-T Cell Therapy in MS
CAR T Therapy: The NEX-T Frontier in MS, a BMS non-promotional symposium at ECTRIMS 2024, presents a thought-provoking view on the potential role of CAR-T cell therapy in Multiple Sclerosis. 𝗙𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀𝗼𝗻𝗹𝘆. 𝗧𝗵𝗶𝘀 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝘄𝗮𝘀 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗲𝗱 𝗯𝘆 𝗕𝗿𝗶𝘀𝘁𝗼𝗹 𝗠𝘆𝗲𝗿𝘀 𝗦𝗾𝘂𝗶𝗯𝗯. 𝗕𝗠𝗦 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱/𝗼𝗿 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗺𝗮𝘆 𝗯𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗲𝗱. (IMM-GB-2400302) | Date of Prep: June 2025
13
Mins
31 May 2025
Navigating treatment switch in LOPD
This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the 21st…
6
Mins
29 May 2025
Blood-Based Neurology Biomarkers
The landscape of neurology biomarkers has evolved significantly in recent years, affording new clinical insights that are helping to…
7
Mins
22 May 2025
FcRn Blockers in gMG A Case-Study
Generalised myasthenia gravis (gMG) is a rare and chronic IgG-mediated autoimmune neuromuscular disease that causes fluctuating and…
5
Mins
21 May 2025
Perampanel as Early Add-On
Leading neurologist discusses evidence from a real-world post hoc analysis of the PERMIT study supporting perampanel as early add-on…
8
Mins
2 May 2025
Clinical Advancements in Becker Muscular Dystrophy
Becker is a serious, progressive muscular dystrophy that presents predominantly in males due to an X-linked…
9
Mins
14 Apr 2025
Intravenous Anti-CGRP Therapy for the Treatment of Migraine
This promotional advertorial article has been fully commissioned by Lundbeck Ltd. UK PI & AER info is available within the article…
7
Mins
13 Mar 2025
New Horizons for Metachromatic Leukodystrophy
This article summarises an Orchard Therapeutic-sponsored symposium titled ‘New horizons for metachromatic leukodystrophy – with the advent…
7
Mins
13 Mar 2025
Does the Gut Microbiome Influence the Efficacy of Psychiatric Drugs?
Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified specific…
5
Mins
13 Mar 2025
Systemic Health Impact of Leaky Barriers in the Oral-Gut-Brain Axis
The human body is a holistic system, interconnected by the circulatory, nervous, lymphatic, endocrine, and immune systems that facilitate…
5
Mins
13 Mar 2025
Infliximab-Induced Multifocal Motor Neuropathy
Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder characterised by progressive, asymmetric muscle weakness…
2
Mins
11 Feb 2025
Targeting Tau in Early Alzheimer’s Disease
Phase 2 randomised controlled trial (RCT) of BMS-986446, a monoclonal antibody targeting the tau microtubule binding region (MTBR)…
24 Jan 2025
Retracted: Early Intervention in MS
This article has now been retracted and a retraction statement has been published.
8
Mins
16 Jan 2025
Long-Term Patient Outcomes: The Role of Sustained Treatment Efficacy in Myasthenia Gravis
There have been great advances in the field of generalised myasthenia gravis (gMG) in recent years, but many patients remain dissatisfied…
9
Mins
12 Dec 2024
The CORE-VNS study: Design and Interim Analysis
This article summarises a LivaNova-sponsored symposium entitled ‘The Power of Real-World Evidence with CORE-VNS’, delivered on 7th…
31 Oct 2024
Tackling Infectious Diseases
This interactive article summarises key discussions from GSK sponsored symposia that took place during the ESCMID Global Congress 2024, held from 27–30th April 2024 in Barcelona, Spain.
4 Oct 2024
The Unspeakable Disease: A Tale of Two Siblings
The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease…
11
Mins
12 Sep 2024
Early Recognition, Diagnosis, and Treatment of Friedreich Ataxia
At the 2024 European Association of Neurology (EAN) Congress, one satellite symposium discussed the recognition, diagnosis, and treatment…
6
Mins
27 Aug 2024
Understanding Developmental and Epileptic Encephalopathies
Developmental and epileptic encephalopathy (DEE) refers to a collection of rare and severe epilepsies that feature both seizures and…
8
Mins
13 Aug 2024
Reimagining Myasthenia Gravis Care
Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies targeting proteins on the neuromuscular junction. Around 85%…
8
Mins
13 Aug 2024
Update on Daridorexant for Insomnia
During this symposium, held at the 10th Congress of the European Academy of Neurology (EAN), speakers highlighted that chronic insomnia…
2
Mins
13 Aug 2024
Nipocalimab and gMG: Top Line Results from the Phase III Vivacity-MG3 Study
Nipocalimab, a high-affinity, fully human, aglycosylated, effectorless, monoclonal antibody, has been developed as an add-on treatment…
5
Mins
13 Aug 2024
Diagnosing Synucleinopathies
Parkinson’s disease (PD) is the second-most common neurodegenerative disease after Alzheimer’s disease (AD), with an estimated…
9
Mins
13 Aug 2024
Patterns of Laryngeal Changes on Clinical Application of Mechanical Insufflation-Exsufflation
Individuals with neuromuscular diseases (NMD), where deterioration in bulbar function coexists with respiratory muscle weakness, are at…
10
Mins
13 Aug 2024
A Rare Case of Cervical Intramedullary Spinal Cord Abscess
The occurrence of intramedullary spinal cord abscesses (ISCA) is rare, a phenomenon attributable to a confluence of physiological and…
5
Mins
13 Aug 2024
Bromocriptine in the Management of Central Hyperthermia
Fever is a common medical issue encountered in neurorehabilitation units. The most common cause of fever is infection; the common…
7
Mins
1 Aug 2024
Interview: Kailash Bhatia
I completed my neurology training in Mumbai, India. At the end of my general medical degree, I was influenced by a top-rate neurologist…
6
Mins
19 Jul 2024
Roundtable Interview: Olivier Rascol and Wassilios Meissner
When I started as a neurologist and a clinical pharmacologist, there were a lot of interesting developments in movement disorders…
9
Mins
13 Jun 2024
Balancing Exercise and Contraction-induced Muscle Injury in Muscular Dystrophies
The rare diseases Duchenne and Becker are X-linked recessive neuromuscular disorders.1 They are characterised by progressive…
8
Mins
19 Mar 2024
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Masterclass Event Summary
A masterclass initiated, organised, and funded by UCB, sought to advance understanding and expertise of myelin oligodendrocyte…
8
Mins
15 Mar 2024
Impact of Non-Seizure Symptoms in Dravet Syndrome and Lennox-Gastaut Syndrome
Non-seizure symptoms in Dravet and Lennox-Gastaut syndromes can affect speech, gait, appetite, mood, development, and sleep and impact…
8
Mins
14 Dec 2023
Spasticity Following Acute Stroke
Many patients experience impairment following a stroke, including motor or cognitive impairment, urinary incontinence, dysphagia…
8
Mins
14 Dec 2023
Tackling Becker Muscular Dystrophy
First described by German physician Peter Emil Becker in the 1950s, Becker is an X-linked genetic recessive disorder. Like Duchenne…
7
Mins
20 Nov 2023
A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is estimated to affect approximately 300,000 individuals worldwide…
11
Mins
4 Oct 2023
Lennox–Gastaut Syndrome: Challenges in Diagnosis – Interviews with Two Key Opinion Leaders
Lennox–Gastaut syndrome (LGS) is a severe childhood-onset epilepsy syndrome that can be challenging to identify due to its heterogeneous and..
13
Mins
14 Sep 2023
The Unspeakable Disease: A Tale of Two Siblings
The deficiency of arylsulfatase A due to the mutations in the ARSA gene is the cause of a rare inherited lysosomal storage disease…
6
Mins
14 Sep 2023
Assessment of Post-Traumatic Stress Disorder in Patients Who Recovered from COVID-19
It is essential to address psychological health, particularly post-traumatic stress disorder (PTSD), among patients who have recovered from…
11
Mins
15 Aug 2023
Focal Onset Seizures: New Treatment Options in The Clinical Practice
Carreño began by discussing the spectrum of uncontrolled epilepsies. They stressed that uncontrolled epilepsy does not necessarily…
15 Aug 2023
Retracted: A Spotlight on Friedreich Ataxia: Optimising the Patient Journey from Diagnosis to Disease Management
This article has now been retracted and a retraction statement has been published.
6
Mins
15 Aug 2023
Development of the Clinical Myotonia Rating Scale and a Mexiletine Prescribing and Monitoring Algorithm for Patients with Non-Dystrophic Myotonia
In the rare neuromuscular disorders classed as NDM, muscle stiffness (myotonia) is the major symptom and is defined by a delayed muscle…
8
Mins
15 Aug 2023
Mitochondrial DNA Maintenance Disorders: Impact of Impaired Deoxynucleoside Triphosphates Metabolism
The maintenance of mitochondrial DNA (mtDNA) is dependent upon several nuclear gene-encoded proteins including enzymes forming the…
4
Mins
15 Aug 2023
Interview: Hugh Selsick
My science degrees were pivotal in fuelling my passions and setting out my career path. During my undergraduate physiology degree…
7
Mins
15 Aug 2023
Cerebrotendinous Xanthomatosis: A Clinical Series Illustrating the Radiological Findings
Cerebrotendinous xanthomatosis (CTX) is a unique disease with an autosomal recessive inheritance, occurring due to the accumulation…
7
Mins
15 Aug 2023
Study for Assessment of Mental Health in Survivors of COVID-19
COVID-19 infection was first reported in December 2019 in Wuhan, China, as a pneumonia outbreak presenting with fever…
6
Mins
15 Aug 2023
Lymphoma of Nervous System or the Great Imitator in Neurology
Primary and secondary lymphoma of the central nervous system (CNS) is a rare case of non-Hodgkin lymphoma. The World…
7
Mins
13 Jul 2023
Isolated Sacral Tuberculosis: A Rare Case Report and
Literature Review
Tuberculosis (TB) is an infectious disease caused by the transmission of Mycobacterium tuberculosis bacillary complex…
8
Mins
3 May 2023
Editor's Pick: Orthostatic Hypotension and Concomitant Paraneoplastic Syndromes: A Case Report
Paraneoplastic autonomic neuropathy is a syndrome with an unclear aetiology and wide array of symptoms. Some studies have identified a strong autoimmune component in the development of paraneoplastic autonomic neuropathy, though some aetiologies are non-immune in nature.
2
Mins
2 Mar 2023
From CoNFLict to Confidence: Solving a Diagnostic Dilemma Using Neurofilament Light – A Case Report
Measurement of fluid biomarkers of neurodegeneration is an emerging approach offering improved diagnostic accuracy of neuropsychiatric conditions, particularly for atypical presentations. This article reports a case where the diagnosis of delirium with dementia was revised based on biomarker analysis, enabling treatment of a primary mood disorder with resolution of recurrent disabling psychiatric symptoms.
8
Mins
20 Feb 2023
Benzodiazepines in Dementia: Review of Clinical Evidence
In the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), Alzheimer’s disease (AD [named after the German psychiatrist and neuropathologist, Alois Alzheimer, who first described it]), is considered as a major or mild neuro-cognitive disorder…
5
Mins
17 Feb 2023
Hearts are NOT Made to Be Broken: Expert Opinion on Amyloid Light-Chain Cardiac Amyloidosis
Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.
11
Mins
31 Jan 2023
The Efficacy and Safety of SARS-CoV-2 Vaccinations in People with Multiple Sclerosis
While people with multiple sclerosis (MS) are not more likely to contract COVID-19, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19-related complications may be higher for people with MS who have comorbidities or who are taking certain disease modifying therapies (DMT).
7
Mins
8 Dec 2022
Tailoring Motor Fluctuation Treatment: Beyond Levodopa Dose Adjustment
Fox emphasised that PD is one of the fastest-growing neurological disorders. Disability and deaths related to it have more than doubled from 1990–2015. Its prevalence is expected to grow exponentially by 2040, affecting approximately 12.9 million individuals worldwide.
10
Mins
8 Dec 2022
The Pathophysiological Relationship Between Migraine and SARS-CoV-2 Infection
People with migraine, and individuals with other neurological conditions, have suffered in multiple aspects during the COVID-19 pandemic. This paper will discuss the factors that impacted the neurology department.
13
Mins
8 Dec 2022
Mexiletine in the Treatment of Non-dystrophic Myotonia: Interviews with Six Medical Experts
NDM includes a group of rare hereditary neuromuscular disorders caused by mutations in the genes that encode sodium or chloride muscle channels.1 Myotonia is the hallmark symptom of NDM and presents as muscle stiffness, often associated with pain, fatigue, and weakness, which can limit function.
9
Mins
8 Dec 2022
Adult-Onset Idiopathic Cervical Dystonia
Adult-onset idiopathic focal dystonia is the most common type of primary dystonia, and adult-onset idiopathic cervical dystonia (AOICD) is its most prevalent phenotype.
11
Mins
20 Sep 2022
Cotard’s Delusion with Sequelae of Adult Onset Failure to Thrive: A Case Report
Patients can present with chief complaints and symptoms that differ from the eventual diagnoses. The differences between aetiologies versus complications must be appreciated through careful evaluation and use of clinical investigations, laboratory testing, trial of hypotheses, and clinical gestalt.
8
Mins
22 Aug 2022
Diencephalic Syndrome: Anaesthetic Management and Post-Operative Complications
Diencephalic syndrome (DS), first described by Russell in 1951, is a rare cause of failure to thrive in infants and young children with preservation of linear growth.
9
Mins
9 Aug 2022
Implications of the First Ex Vivo Gene Therapy Approved for Treating Early-Onset Metachromatic Leukodystrophy
MLD is caused by an accumulation of sulfatides in various organs and predominantly the central nervous system (CNS). Patients have an initial period of normal development, then experience developmental delay or stagnation (Figure 1).
11
Mins
9 Aug 2022
Improving The Management of Non-dystrophic Myotonia to Benefit Care Delivery and Improve Patient Outcomes
Non-dystrophic myotonias (NDM) are a group of rare muscle disorders with a reported prevalence of 0.75−1.7 per 100,000 population (Figure 1).
9
Mins
9 Aug 2022
Sex-Related Differences in Symptoms Among Patients Presenting with Acute Stroke: A Systematic Review and Meta-analysis
Recognising acute stroke symptoms is crucial in providing timely treatment. However, evidence suggests that females often experience unique symptoms compared with males, resulting in delays to seeking medical attention and treatment.
6
Mins
9 Aug 2022
Never Too Late to Treat NMDAR Encephalitis: A Paediatric Case Report and Review of Literature
Dysfunction of N-methyl-D-aspartate receptors (NMDAR) have been proposed as the aetiology for multiple neuropsychiatric diseases. While overactivity of NMDA receptors causing excitotoxicity has been implicated in epilepsy, dementia, and stroke, low activity may produce symptoms resembling those of schizophrenia.
9
Mins
25 Apr 2022
Editor's Pick: Adiposity and Neurological Disorders: A Review
Obesity and increased adipose tissue are linked with inflammation, the driving force behind neurologic disorders like Alzheimer’s disease…
4
Mins
28 Feb 2022
A Rare Case of Multiple Cranial Nerve Palsies as the First Presentation of Hepatocellular Carcinoma: A Case Report and Review of Literature
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It mainly occurs in patients with chronic liver…
4
Mins
31 Jan 2022
A Case Report on a Novel
PINK1
Gene Mutation in a Female with a Neurodegenerative Disorder
Parkinson’s disease (PD) is a progressive neurodegenerative disorder attributed to the loss of dopaminergic neurons in the substantia nigra.
11
Mins
27 Jan 2022
New Advances in the Treatment of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy
Both spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are monogenic neuromuscular diseases, which cause progressive proximal-to-distal muscular weakness, leading to loss of motor function and related pulmonary and musculoskeletal co-morbidities and reduced survival.
6
Mins
9 Dec 2021
Neurofibromatosis Type 1: Burden of Disease in Patients with Plexiform Neurofibromas
NF1 is an autosomal dominant disorder, arising from a mutation in the gene that encodes neurofibromin. It is a tumour-predisposing…
6
Mins
9 Dec 2021
Management and Multi-specialty Approach in the Evolving Treatment Landscape of Neurofibromatosis Type 1 Plexiform Neurofibromas
Neurofibromatosis Type 1 (NF1) is a rare disease, occurring in approximately 1 in 3,000 people. Among the numerous manifestations…
4
Mins
25 Nov 2021
Emerging Treatment Strategies for Motor Fluctuation Management: Therapeutic Options for Newly Detected Motor Fluctuations
At the 7th Congress of the European Academy of Neurology (EAN), held virtually in June 2021, real-world data on the efficacy and safety of…
7
Mins
21 Oct 2021
Assessing Disease Activity and Progression in Patients with Relapsing–Remitting Multiple Sclerosis: Interviews with Two Key Opinion Leaders
Multiple sclerosis is a common and chronic neurological disorder that affects over 2.8 million individuals worldwide every year…
12
Mins
19 Oct 2021
Cannabinoids in the Treatment of Epilepsy: A Review
Cannabidiol (CBD) comes from Cannabis sativa, which is a medicinal plant known to have several properties. Several types of extracts from…
3
Mins
8 Sep 2021
Interview: Claudio Bassetti
Ioannis Sfontouris | President of the European Academy of Neurology (EAN); Professor of Neurology and Head of the Neurology Department… %
8
Mins
3 Aug 2021
Motor Fluctuation Management in Parkinson’s Disease: Now and What Next?
Here the speakers present highlights of a virtual satellite symposium at the 7th Congress of the European Academy of Neurology…
3
Mins
3 Aug 2021
INTERVIEW: SERGIO BARANZINI
Both my parents were clinical biochemists, and ran their lab next to our house, so I grew up in between microscopes, electrophoretic apparatuses…
4
Mins
3 Aug 2021
INTERVIEW: KRISTIAN STEEN REDERIKSEN
Since medical school I have had a special interest in cognitive neurology and higher cortical functions, and actually started out doing a…
5
Mins
3 Aug 2021
A Case Report: Internal Carotid Artery Dissection Presenting as Hoarseness Secondary to Vocal Cord Palsy
Vocal cord paralysis or weakness can be a symptom of malignancy, caused by viral infection, iatrogenic, a result of trauma, idiopathic…
4
Mins
3 Aug 2021
Turner Syndrome and Craniosynostosis: An Unusual Combination
Turner syndrome (TS) is one of the most frequent chromosomal aberrations, caused by the partial or complete loss of one X chromosome…
5
Mins
3 Aug 2021
A Case of Subacute Combined Degeneration as a Manifestation of Pernicious Anaemia
The patient was admitted to the hospital for further study of the neurological changes, treatment of serious anaemia…
7
Mins
3 Aug 2021
Successful Management of Parsonage–Turner Syndrome with Steroids in the Post-acute Weakness Phase: A Case Report
Parsonage–Turner Syndrome (PTS) is a rare disease of the brachial plexus of unclear aetiology. The authors present a case of PTS with a rare combination of unilateral brachial plexus, phrenic nerve, and recurrent laryngeal nerve injuries.
24
Mins
30 Jun 2021
Clarity on Cannabinoid-Based Products in Medicine
This document aims to provide an overview of the clinical and regulatory challenges faced in the use of cannabinoid-based products in medicine, without becoming a comprehensive humanity review of the literature on the medical possibilities of cannabinoids.
10
Mins
17 Jun 2021
Understanding the Impact of Non-Dystrophic Myotonia on Patients and Caregivers: Results from a Burden of Disease Healthcare Survey
Non-dystrophic myotonias (NDM) manifest as delayed muscle relaxation (myotonia) leading to muscle stiffness that may diminish or worsen…
4
Mins
26 Apr 2021
A Successful Treatment of Chronic Migraine with Hyperbaric Oxygen Therapy
Migraines involve intense head pain, which severely affects the activities of daily living, and is the is the third most common disease in the world…
9
Mins
10 Dec 2020
Clinical Profile and Outcome of Children with Acute Central Nervous System Infection in Kerala, India
Infection of the central nervous system is a significant cause of morbidity and mortality in children.
9
Mins
9 Dec 2020
The Role of Sphingosine 1-Phosphate Receptor Modulators in the Treatment of Multiple Sclerosis
Neurologists are familiar with S1P receptor modulators as a class, largely based on several years’ experience with fingolimod. Siponimod and ozanimod…
11
Mins
3 Nov 2020
Empowering Physicians to Advance the Future of Alzheimer’s Disease Management and Care
This series of four talks was aimed at providing healthcare professionals (HCP) with an understanding of the need for early diagnosis of AD to enable refined care
4
Mins
13 Jul 2020
Interview: Professor Michael Barnes
I became interested whilst working in multiple sclerosis clinics roughly 20 years ago. Some of my patients came to the clinic and told me that they…
11
Mins
13 Jul 2020
Moving from The Periphery to The Core of The Matter – Where Does Opicapone▼ Fit in Parkinson’s Disease?
Presented here are highlights of a virtual satellite symposium from the European Academy of Neurology (EAN) 2020 Virtual Congress…
4
Mins
13 Jul 2020
An Evaluation of the Studies on the Therapeutic Effects of Yoga in People with Dementia
The global population is ageing, and the prevalence of dementia is increasing. Current conventional drug therapy lacks efficacy; therefore…
12
Mins
13 Jul 2020
Editor's Pick: Current Paradigms to Explore the Gut Microbiota Linkage to Neurological Disorders
The human body harbours a diverse community of symbiotic, commensal, and pathogenic micro-organisms including bacteria, viruses, and fungi…
15
Mins
13 Jul 2020
Clinical Controversies in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative condition with few effective treatments. New techniques have been developed to provide a more accurate diagnosis, earlier in the disease course.
11
Mins
13 Jul 2020
Neuroinfections: Presentation, Diagnosis, and Treatment of Meningitis and Encephalitis
This article serves as a review of the approach to a patient with suspected neurological infection with an emphasis on clinical presentation, diagnosis, and treatment of the major causes of meningitis and encephalitis.
3
Mins
13 Jul 2020
Case Report of Schwannomas: Benign Tumour of the Peripheral Nerve Sheath
Schwannomas are benign, painless, firm nodules, 1–2 cm in diameter, that develop from the Schwann cells of peripheral nerve sheaths…
6
Mins
13 Jul 2020
Neuroinflammation: A Common Line Between the Wnt Pathway and Toll-Like Receptors
Neurodegenerative disorders constitute a worldwide concern attributable to the ageing of the human population.
Loading posts...
« Previous
1
…
12
13
14
15
16
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View